AMArpi Minassian

Arpi Minassian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arpi Minassian has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • William Perry

    Department of Psychiatry, University of California San Diego, San Diego, CA, USA

    12 shared publications
  • Mark A. Geyer

    Department of Psychiatry, University of California San Diego, San Diego, CA, USA

    7 shared publications
  • Brook L. Henry

    Department of Psychiatry, University of California San Diego, La Jolla, CA, United States

    6 shared publications
  • Jared W. Young

    Department of Psychiatry, University of California San Diego, San Diego, CA, USA

    4 shared publications
  • Caroline M. Nievergelt

    Department of Psychiatry, University of California San Diego, La Jolla, USA

    2 shared publications
  • Dewleen G. Baker

    Center of Excellence for Stress and Mental Health, Veteran's Administration, San Diego, California2Department of Psychiatry, University of California, San Diego, La Jolla, California3Department of Psychiatry, Veterans Administration San Diego Healthcare S

    2 shared publications

Latest Publications

  • Open Access

    The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania

    by Arpi Minassian, Jared W. Young, Mark A. Geyer, John R. Kelsoe, William Perry

    Background: The catechol-O-methyltransferase (COMT) Val158Met gene influences cognition and behavior in psychiatric illnesses; its low-activity allele, methionine (Met), may be associated with behavior reflecting catecholamine overactivity. Heightened motor activity and increased positive valence are central features of bipolar disorder (BD) and have been quantified in the human Behavioral Pattern Monitor (hBPM), an exploration paradigm based upon the rodent open field. We examined whether hBPM behavior was related to the COMT gene in a small sample of manic BD patients. Methods: Twenty-six acutely hospitalized manic BD patients were genotyped for the COMT Val158Met polymorphism and tested in the hBPM, an unfamiliar room containing novel objects. Movements around the hBPM and object interactions were video-recorded for 15 min and rated. Results: Met homozygote BD patients demonstrated significantly more interactions with multiple objects and more time spent with objects in the hBPM. Valine (Val) homozygote patients exhibited the least object exploration, while heterozygote patients demonstrated intermediate levels. Conclusion: This preliminary study suggests that arousal and positive valence are influenced in a linear fashion by COMT, presumably due to increased catecholamine in frontal regions, but these findings require replication in a larger sample. The hBPM can enable cross-species and transdiagnostic studies to inform neurobiology of psychiatric disorders.


  • Everyday functional ability in HIV and methamphetamine dependence

    by Arpi Minassian, Brook L. Henry, Jennifer E. Iudicello, Erin E. Morgan, Scott L. Letendre, Robert K. Heaton, William Perry


  • 890. Bipolar Disorder and Cannabis Use: A Survey of Substance Use Patterns

    by Jared Young, Karen Kloezeman, Meghan McIlwain, Dustin Kreitner, Arpi Minassian, William Perry

  • Amphetamine increases activity but not exploration in humans and mice

    by Arpi Minassian, Jared W. Young, Zackary A. Cope, Brook L. Henry, Mark A. Geyer, William Perry

    Rationale Cross-species quantification of physiological behavior enables a better understanding of the biological systems underlying neuropsychiatric diseases such as bipolar disorder (BD). Cardinal symptoms of manic BD include increased motor activity and goal-directed behavior, thought to be related to increased catecholamine activity, potentially selective to dopamine homeostatic dysregulation. Objectives The objective of this study was to test whether acute administration of amphetamine, a norepinephrine/dopamine transporter inhibitor and dopamine releaser, would replicate the profile of activity and exploration observed in both humans with manic BD and mouse models of mania. Methods Healthy volunteers with no psychiatric history were randomized to a one-time dose of placebo (n = 25), 10 mg d-amphetamine (n = 18), or 20 mg amphetamine (n = 23). Eighty mice were administered one of four doses of d-amphetamine or vehicle. Humans and mice were tested in the behavioral pattern monitor (BPM), which quantifies motor activity, exploratory behavior, and spatial patterns of behavior. Results In humans, the 20-mg dose of amphetamine increased motor activity as measured by acceleration without marked effects on exploration or spatial patterns of activity. In mice, amphetamine increased activity, decreased specific exploration, and caused straighter, one-dimensional movements in a dose-dependent manner. Conclusions Consistent with mice, amphetamine increased motoric activity in humans without increasing exploration. Given that BD patients exhibit heightened exploration, these data further emphasize the limitation of amphetamine-induced hyperactivity as a suitable model for BD. Further, these studies highlight the utility of cross-species physiological paradigms in validating biological mechanisms of psychiatric diseases.


  • Open Access

    Association of Predeployment Heart Rate Variability With Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines

    by Arpi Minassian, Adam X. Maihofer, Dewleen G. Baker, Caroline M. Nievergelt, Mark A. Geyer, Victoria B. Risbrough, for the Marine Resiliency Study Team

    Posttraumatic stress disorder (PTSD) is, historically and currently, a significant public health problem in individuals deployed to war. Lifetime prevalence of the disorder is approximately 19% in Vietnam-era combat veterans1 and 13% to 15% in US military servicemembers serving in this era’s conflicts in Iraq and Afghanistan2,3 compared with the 8% general prevalence rate of PTSD in the United States.4 These differences in prevalence rates may be in part attributable to variations in the disorder’s diagnostic criteria or how it is assessed. Regardless, psychological and functional consequences of PTSD can be devastating (eg, high suicide rates5 and long-term disability with substantial impairment in functioning6). Furthermore, PTSD is associated with several adverse health consequences.7,8


  • Heart Rate Variability Characteristics in a Large Group of Active-Duty Marines and Relationship to Posttraumatic Stress

    by Arpi Minassian, Mark A. Geyer, Dewleen G. Baker, Caroline M. Nievergelt, Daniel T. O’connor, Victoria B. Risbrough

    Objective Heart rate variability (HRV), thought to reflect autonomic nervous system function, is lowered under conditions such as posttraumatic stress disorder (PTSD). The potential confounding effects of traumatic brain injury (TBI) and depression in the relationship between HRV and PTSD have not been elucidated in a large cohort of military service members. Here we describe HRV associations with stress disorder symptoms in a large study of Marines while accounting for well-known covariates of HRV and PTSD including TBI and depression. Methods Four battalions of male active-duty Marines (n = 2430) were assessed 1 to 2 months before a combat deployment. HRV was measured during a 5-minute rest. Depression and PTSD were assessed using the Beck Depression Inventory and Clinician-Administered PTSD Scale, respectively. Results When adjusting for covariates, including TBI, regression analyses showed that lower levels of high-frequency HRV were associated with a diagnosis of PTSD (β = −0.20, p = .035). Depression and PTSD severity were correlated (r = 0.49, p < .001); however, participants with PTSD but relatively low depression scores exhibited reduced high frequency compared with controls (p = .012). Marines with deployment experience (n = 1254) had lower HRV than did those with no experience (p = .033). Conclusions This cross-sectional analysis of a large cohort supports associations between PTSD and reduced HRV when accounting for TBI and depression symptoms. Future postdeployment assessments will be used to determine whether predeployment HRV can predict vulnerability and resilience to the serious psychological and physiological consequences of combat exposure.


  • Prepulse Inhibition in HIV-Associated Neurocognitive Disorders

    by Arpi Minassian, Brook L. Henry, Steven Paul Woods, Florin Vaida, Igor Grant, Mark A. Geyer, William Perry, The Translational Methamphetamine AIDS Research Center (TMARC) Group

    Sensorimotor inhibition, or the ability to filter out excessive or irrelevant information, theoretically supports a variety of higher-level cognitive functions. Impaired inhibition may be associated with increased impulsive and risky behavior in everyday life. Individuals infected with HIV frequently show impairment on tests of neurocognitive function, but sensorimotor inhibition in this population has not been studied and may be a contributor to the profile of HIV-associated neurocognitive disorders (HAND). Thirty-seven HIV-infected individuals (15 with HAND) and 48 non-infected comparison subjects were assessed for prepulse inhibition (PPI), an eyeblink startle paradigm measuring sensorimotor gating. Although HIV status alone was not associated with PPI deficits, HIV-positive participants meeting criteria for HAND showed impaired PPI compared to cognitively intact HIV-positive subjects. In HIV-positive subjects, PPI was correlated with working memory but was not associated with antiretroviral therapy or illness factors. In conclusion, sensorimotor disinhibition in HIV accompanies deficits in higher-order cognitive functions, although the causal direction of this relationship requires investigation. Subsequent research on the role of sensorimotor gating on decision-making and risk behaviors in HIV may be indicated. (JINS, 2013,19, 1–9)


  • Open Access

    Repeated Assessment of Exploration and Novelty Seeking in the Human Behavioral Pattern Monitor in Bipolar Disorder Patients and Healthy Individuals

    by Arpi Minassian, Brook L. Henry, Jared W. Young, Virginia Masten, Mark A. Geyer, William Perry

    Exploration and novelty seeking are cross-species adaptive behaviors that are dysregulated in bipolar disorder (BD) and are critical features of the illness. While these behaviors have been extensively quantified in animals, multivariate human paradigms of exploration are lacking. The human Behavioral Pattern Monitor (hBPM), a human version of the animal open field, identified a signature pattern of hyper-exploration in manic BD patients, but whether exploratory behavior changes with treatment is unknown. The objective of this study was to assess the sensitivity of the hBPM to changes in manic symptoms, a necessary step towards elucidating the neurobiology underlying BD. Twelve acutely hospitalized manic BD subjects and 21 healthy volunteers were tested in the hBPM over three sessions; all subjects were retested one week after their first session and two weeks after their second session. Motor activity, spatial and entropic (degree of unpredictability) patterns of exploration, and interactions with novel objects were quantified. Manic BD patients demonstrated greater motor activity, extensive and more unpredictable patterns of exploration, and more object interactions than healthy volunteers during all three sessions. Exploration and novelty-seeking slightly decreased in manic BD subjects over the three sessions as their symptoms responded to treatment, but never to the level of healthy volunteers. Among healthy volunteers, exploration did not significantly decrease over time, and hBPM measures were highly correlated between sessions. Manic BD patients showed a modest reduction in symptoms yet still demonstrated hyper-exploration and novelty seeking in the hBPM, suggesting that these illness features may be enduring characteristics of BD. Furthermore, behavior in the hBPM is not subject to marked habituation effects. The hBPM can be reliably used in a repeated-measures design to characterize exploration and novelty seeking and, in parallel with animal studies, can contribute to developing treatments that target neuropsychiatric disease.